Format

Send to

Choose Destination
J Dermatol. 1994 Oct;21(10):729-31.

Nodulocystic acne: oral gugulipid versus tetracycline.

Author information

1
Department of Dermatology, C.G.H.S., Bajaj Nagar, Jaipur, India.

Abstract

Twenty patients with nodulocystic acne were randomly allocated to one of two treatment schedules: 1) Tetracycline 500 mg or 2) Tab. Gugulipid (equivalent to 25 mg guggulsterone). Both were taken twice daily for 3 months, and both produced a progressive reduction in the lesions in the majority of patients. With tetracycline, the percentage reduction in the inflammatory lesions was 65.2% as compared to 68% with gugulipid; on comparison, this difference was statistically insignificant (P > 0.05). Follow-up at 3 months showed a relapse in 4 cases on tetracyline and 2 cases on gugulipid. An interesting observation was that the patients with oily faces responded remarkably better to gugulipid.

PMID:
7798429
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center